Krebs Biochemicals & Industries has informed that trading window for dealings in securities of the Company shall remain closed with effect from close of business hours on June 30, 2026 un-till 48 hours after the declaration of Unaudited Financial Results for 1st quarter ended June 30, 2026 for promoters, directors, designated persons, their immediate relatives and all connected persons covered under the said code. The date of the Board meeting for consideration of the said Unaudited Financial Results would be intimated to the stock exchanges in due course of time.
The above information is a part of company’s filings submitted to BSE.
